Physician
Mercy West Urgent Care INC
Mercy West Urgent Care INC was paid $3.54M by Medicaid between Jan 2018 and Nov 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoMERCY WEST URGENT CARE INC
TURLOCK, CA 95382
TURLOCK, CA 95382
33aNPI1356791099assigned 06/14/2016
33bProvider typeEmergency Medicine Physician
28Total paid$3.54M
24GClaims102,695
24DCodes billed41
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Emergency Medicine Physician providers in California
Rank by total paid#135 of 988
Median peer was paid$32K
This provider vs. median112×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,563 | $468K | |
| 2019 | 12,017 | $439K | |
| 2020 | 7,630 | $285K | |
| 2021 | 12,019 | $390K | |
| 2022 | 19,728 | $634K | |
| 2023 | 21,785 | $684K | |
| 2024incomplete | 17,953 | $640K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 23,250 | 20,893 | $1.06M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 23% | 10,065 | 10,009 | $818K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 7,322 | 7,310 | $450K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 11,910 | 11,021 | $394K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 13,876 | 12,526 | $369K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.3% | 5,410 | 5,011 | $118K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.6% | 2,284 | 2,189 | $92K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.4% | 5,564 | 5,190 | $85K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 6,112 | 5,989 | $40K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,254 | 2,093 | $33K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,038 | 1,890 | $24K |
| 87428 | <1% | 298 | 295 | $19K |
29 more codes
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 962 | $11K |
| 81002 | <1% | 3,570 | $7K | |
| 87807 | <1% | 426 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 340 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 200 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 52 | $3K |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 229 | $2K |
| 81025 | <1% | 480 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 34 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 49 | $965.34 |
| 87400 | <1% | 61 | $726.37 | |
| 69209 | <1% | 37 | $387.83 | |
| 99051 | <1% | 2,791 | $375.70 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 41 | $367.54 |
| 90714 | <1% | 13 | $363.29 | |
| 93000 | <1% | 12 | $318.61 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15 | $254.69 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 13 | $249.00 |
| 94760 | <1% | 124 | $242.49 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 26 | $233.46 |
| 99072 | <1% | 2,363 | $166.31 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 12 | $146.77 |
| 81003 | <1% | 73 | $128.84 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $114.40 |
| 87088 | <1% | 16 | $97.28 | |
| 82947 | <1% | 27 | $79.42 | |
| 85018 | <1% | 42 | $76.16 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 26 | $57.90 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 262 | $52.78 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGEORGIES, RAMI (MD)
| Provider | Location | Paid |
|---|---|---|
| California Urgent Care Center Professional Corporation | Stockton, CA | $19.59M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.